Skip to main content

Research Repository

Advanced Search

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015.

Yang

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Thumbnail


Authors



Abstract

This paper summarizes the proceedings of a workshop held at Trinity Hall, Cambridge to discuss comparability and includes additional information and references to related information added subsequently to the workshop. Comparability is the need to demonstrate equivalence of product after a process change; a recent publication states that this 'may be difficult for cell-based medicinal products'. Therefore a well-managed change process is required which needs access to good science and regulatory advice and developers are encouraged to seek help early. The workshop shared current thinking and best practice and allowed the definition of key research questions. The intent of this report is to summarize the key issues and the consensus reached on each of these by the expert delegates.

Acceptance Date May 17, 2016
Publication Date Jul 12, 2016
Publicly Available Date Mar 29, 2024
Journal Regenerative Medicine
Print ISSN 1746-0751
Publisher Future Medicine
Pages 483 - 492
DOI https://doi.org/10.2217/rme-2016-0053
Keywords advice, comparability, human pluripotent stem cell derived, manufacturing, quality, regulatory
Publisher URL http://www.futuremedicine.com/doi/10.2217/rme-2016-0053

Files




You might also like



Downloadable Citations